Keaven M Anderson

Keaven M Anderson

Merck & Co, Inc.
Verified email at merck.com
Cited by 54602
Clinical trials group sequential design survival analysis multiplicity
Jason Clark

Jason Clark

Biometrics Team Leader, AstraZeneca
Verified email at astrazeneca.com
Cited by 3573
Clinical Trials Biometrics Biostatistics Group Sequential Design
Se Yoon Lee

Se Yoon Lee

Texas A&M University
Verified email at tamu.edu
Cited by 242
Clinical Trials Bayesian Adaptive Design Group Sequential Design Survival Analysis
Qi An

Qi An

Biostatistics, University of Florida
Verified email at ufl.edu
Cited by 162
Group sequential design Survival analysis Clinical trial
Subhayan Mondal

Subhayan Mondal

Statistician, Johnson and Johnson
Verified email at its.jnj.com
Cited by 108
Survival Analysis Group Sequential Design
Pranab Ghosh

Pranab Ghosh

Pfizer Inc.
Verified email at pfizer.com
Cited by 88
Biostatistics Clinical trial Group sequential design multi arm trials adaptive design
Hao Sun

Hao Sun

Biostatistician, Bristol Myers Squibb
Verified email at bms.com
Cited by 8
Clinical Trial Design Dose Finding Dose Optimization Dynamic Borrowing Group Sequential Design